Literature DB >> 1120926

Hemoglobin E, an oxidatively unstable mutation.

H Frischer, J Bowman.   

Abstract

When bloods from 3,159 individuals from the United States, Iran, Ethiopia, and South Vietnam were examined for erythrocytic enzyme deficiencies with a new test utilizing the visible reduction of 2,6-dichlorophenolindophenol by glutathione, gross turbidity was observed in 81 samples. All were from Southeast Asia and 78 contained hemoglobin E. The precipitation rates of various hemoglogins in hemolysates incubated with dichlorophenolindophenol were: Hb EE greater than Hb AE greater than other hemoglobins (A, S, C, D, A2, F, O-Arabia, Rush). Hemoglobin E is an oxidatively unstable hemoglobin, possibly with weakened alpha 1 beta 1 contact; it may result in increased susceptibility to oxidative hemolysis and can be simply detected and differentiated from both Hb C and Hb O-Arabia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120926

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  18 in total

1.  The clinical significance of hemoglobinopathies.

Authors:  M A Ali; S C Wong
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

2.  Hemoglobinopathic erythrocytes affect the intraerythrocytic multiplication of Plasmodium falciparum in vitro.

Authors:  Svetlana Glushakova; Amanda Balaban; Philip G McQueen; Rosane Coutinho; Jeffery L Miller; Ralph Nossal; Rick M Fairhurst; Joshua Zimmerberg
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

3.  Reassessment of a simple chemical method using DCIP for screening for haemoglobin E.

Authors:  L Chapple; A Harris; L Phelan; B J Bain
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

4.  Using Red Cell Indices and Reticulocyte Parameters for Carrier Screening of Various Thalassemia Syndromes.

Authors:  Orathai Tangvarasittichai; Nares Poonanan; Surapon Tangvarasittichai
Journal:  Indian J Clin Biochem       Date:  2016-05-09

5.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

Review 6.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 7.  Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics.

Authors:  Michael Brad Strader; Abdu I Alayash
Journal:  Antioxid Redox Signal       Date:  2016-10-20       Impact factor: 8.401

Review 8.  The hemoglobin E thalassemias.

Authors:  Suthat Fucharoen; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man.

Authors:  P E Carson; R Hohl; M V Nora; G W Parkhurst; T Ahmad; S Scanlan; H Frischer
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

10.  Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria.

Authors:  I A Clark; N H Hunt
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.